Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
7
×
national blog main
7
×
pfizer
7
×
national top stories
san diego blog main
san diego top stories
san francisco blog main
boston blog main
boston top stories
national
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
merck
new york blog main
new york top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
arimoclomol
astrazeneca
bristol-myers squibb
fda
immunotherapy
orphazyme
roche
startups
acute myeloid leukemia
aegle therapeutics
What
cancer
7
×
bio
medical
amid
annual
bombast
caught
clinical
conference
coronavirus
debate
develop
discussion
efforts
esmo
european
meso’s
miss
oncology
pandemic
pfizer’s
presidential
promise
response
roundup
society
tuesday’s
vaccine
viewers
approved
ash
athena
barcelona
biotech
blood
breast
broader
cancer's
ceo
chief
Language
unset
Current search:
cancer
×
" life sciences "
×
pfizer
×
" national blog main "
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
5 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push